Company Description (as filed with the SEC)
We are a specialty biopharmaceutical company, incorporated in Delaware on July 23, 1999. We focus on developing and marketing products to predominantly specialist audiences. We are a fully integrated company and had approximately 526 employees as of December 31, 2012, including approximately 287 employees in our commercial organization, approximately 122 employees in manufacturing and quality, approximately 60 employees in research and development and approximately 57 employees providing administrative support. We reported net revenues in 2012 of $395.3 million compared to $264.3 million reported in 2011. Our fourth quarter 2012 net revenues included $93.6 million related to previously received and deferred up-front and milestone payments related to our European collaboration with Pfizer, Inc. ... More ...